Literature DB >> 23137486

An unusual transmission event of Neisseria meningitidis serogroup W135 type 2a in a healthcare setting, England, 2012.

R Puleston1, C Beck, M Tahir, M Bardhan, P Charlemagne, C Alves, S Ladhani, C Watson, M Ramsay, E Kaczmarksi, R Borrow, S Gray, D Hadlington, M Weinbren, D Bhattacharjee, N Inglis.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23137486

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


× No keyword cloud information.
  4 in total

1.  An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015.

Authors:  Jay Lucidarme; Kevin J Scott; Roisin Ure; Andrew Smith; Diane Lindsay; Bianca Stenmark; Susanne Jacobsson; Hans Fredlund; J Claire Cameron; Alison Smith-Palmer; Jim McMenamin; Steve J Gray; Helen Campbell; Shamez Ladhani; Jamie Findlow; Paula Mölling; Ray Borrow
Journal:  Euro Surveill       Date:  2016-11-10

2.  Interconnected clusters of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11), involving bisexuals and men who have sex with men, with discos and gay-venues hotspots of transmission, Tuscany, Italy, 2015 to 2016.

Authors:  Alessandro Miglietta; Cecilia Fazio; Arianna Neri; Patrizio Pezzotti; Francesco Innocenti; Chiara Azzari; Gian Maria Rossolini; Maria Moriondo; Francesco Nieddu; Stefania Iannazzo; Fortunato D'Ancona; Francesco Paolo Maraglino; Raniero Guerra; Giovanni Rezza; Fabio Voller; Paola Stefanelli
Journal:  Euro Surveill       Date:  2018-08

3.  Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci.

Authors:  C Stinson; C Burman; J Presa; M Abalos
Journal:  Epidemiol Infect       Date:  2020-01-27       Impact factor: 2.451

Review 4.  Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.

Authors:  Sandra Guedes; Isabelle Bertrand-Gerentes; Keith Evans; Florence Coste; Philipp Oster
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.